IndraLab

Statements


USP13 inhibits METTL3. 2 / 2
| 2

reach
"Using a small-molecule inhibitor named Spautin-1 to pharmacologically inhibit USP13 induced METTL3 degradation and exhibited significant therapeutic efficacy both in vitro and in vivo."

reach
"Knockdown or overexpression of USP13 markedly decreased or increased METTL3 protein but not mRNA levels (Fig. 3e, S3)."